Extracorporeal blood oxygenation and ozonation: Clinical and biological implications of ozone therapy

Redox Report

Volumn 10, Issue 3, 2005, Pages 121-130

  Di Paolo, Nicola ^a   Gaggiotti, E ^b   Galli, F ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Antioxidants; Extracorporeal circulation; Lipid peroxidation; Oxidative stress; Oxygen; Ozone therapy

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 8; MALONALDEHYDE; OXYGEN; OZONE; PLASMA PROTEIN; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTERY DISEASE; BLOOD COMPONENT; CHOLESTEROL EMBOLISM; DISEASE SEVERITY; DYSLIPIDEMIA; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; HEMODIALYSIS; HEMOLYSIS; HEPARINIZATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; LIPOMATOSIS; NONHUMAN; OXIDATIVE STRESS; OZONATION; OZONE THERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SHEEP; SUDDEN DEAFNESS; TREATMENT OUTCOME; VALIDATION STUDY;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CELL RESPIRATION; ENDOTHELIAL CELLS; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; IMMUNE SYSTEM; OXIDANTS; OXIDATIVE STRESS; OXYGEN; OZONE;

OVIS ARIES;

EID: 29244437547     PISSN: 13510002     EISSN: 13510002     Source Type: Journal    
DOI: 10.1179/135100005X38888     Document Type: Review

References (58)

1. Bocci V. Oxygen-Ozone Therapy. A Critical Evaluation. London: Kluwer, 2002.
2. Di Paolo N, Bocci V. EBOO (Extracorporeal Blood Oxygenation and Ozonization). Cosenza, Italy: Bios, 2003.
3. Cross CE, Eiserich, JP, Halliwell B. General biological consequences of inhaled environmental toxicants. In: Crystal RG, West JB. (eds) The Lung: Scientific Foundations. Philadelphia, PA: Lippincott-Raven, 1997; 2421-2437.
4. Aubourg P. L'ozone medicale: production, posologie, models d'applications cliniques. Bull Med Paris 1938; 52: 745-749.
5. Moore G, Griffith C, Peters A. Bactericidal properties of ozone and its potential application as a terminal disinfectant. J Food Prot 2000; 63: 1100-1106.
6. Wolff HH. Die Behandlung perripherer Durchblutungs storungen mit Ozon. Erfahr Hk 1974; 23: 181-184.
7. Bocci V. Ozonization of blood for the therapy of viral disease and immunodeficiencies. A hypothesis. Med Hypothesis 1992; 39: 30-34.
8. Valdes RA, Cepero MS, Moraleda GM, Pozo LJ. Ozone therapy in the advance stages of arteriosclerosis obliterans. Angiologia 1993; 45: 146-148.
9. Viebahn R. The Use of Ozone in Medicine, vol. 1, 2nd edn. Heidelberg: Karl F. Haug, 1994; 178-181.
10. Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med 1996; 21: 641-649.
11. Bocci V. Ozone as bioregulator: pharmacology and toxicology of ozone-therapy today. J Biol Regular Homeost Agent 1996; 10: 31-53.
12. Bocci V, Paulesu L. Studies on the biological effects of ozone: 1. Induction of interferon gamma on human leukocytes. Haematologia 1990; 75: 510-515.
13. Di Paolo N, Bocci V, Garosi G et al. Extracorporeal blood oxygenation and ozonation (EBOO) in man. Preliminary report. Int J Artif Organs 2000; 23: 131-141.
14. Viebahn R. Physikalisch-chemische, grundlagen der ozontherapie. Erfahrungsheilkunde 1975; 5: 129-134.
15. Bocci V. Ozone therapy may act as a biological response modifier in cancer. Forsch Komplement 1998; 5: 54-60.
16. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 3rd edn. London: Oxford University Press, 1999.
17. Bocci V, Valacchi G, Corradeschi F et al. Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regulat Homeost Agent 1998; 12: 67-75.
18. Goldstein BD, Balchum OJ. Effect of ozone on lipid peroxidation in the red blood cell. Proc Soc Exp Biol Med 1967; 126: 356-359.
19. Los M, Droge W, Stricker K et al. Hydrogen peroxide as a potent activator of T-lymphocyte functions. Eur J Immunol 1995; 25: 159-165.
20. Leonarduzzi G. The lipid peroxidation end product 4-hydroxy-2,3 nonenal up-regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 1997; 11: 851-857.
21. Bocci V, Valacchi G, Rossi D et al. Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets 1999; 10: 110-116.
22. Freeman BA, Mudd JB. Reaction of ozone with sulphydryls of human erythrocytes. Arch Biochem Biophys 1981; 208: 212-220.
23. Van der Vliet A, O'Neill CA, Eiserich JP, Cross CE. Oxidative damage to extracellular fluids by ozone and possible protective effects of thiols. Arch Biochem Biophys 1995; 321: 43-50.
24. Bocci V, Luzzi E, Corradeshi F et al. Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes. J Biol Regulat Homeost Agent 1998; 12: 67-75.
25. De Groote D. Direct stimulation of cytokine (IL-1β, TNF-α, IL-6, IL-2, IFN-g and GM-CFS) in whole blood. I. Comparison with isolate PBMC stimulation. Cytokine 1992; 4: 239-248.
26. Bocci V, Valacchi G, Corradeschi F, Fanetti G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediat Inflam 1998; 7: 313-317.
27. Hamilton RF, Hazbun ME, Jumper CA. 4-hydroxynonenal mimics ozone-induced modulation of macrophages function ex vivo. Am J Respir Cell Mol Biol 1996; 15: 275-282.
28. Jaspers I, Flescher E, Chen LC. Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. Am J Physiol 1997; 272: 504-511.
29. Wainer DDM, Burton GW, Ingold KU, Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. FEBS Lett 1985; 187: 33-37.
30. Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: The role of lipid ozonation products. Free Radic Biol Med 1995; 19: 935-941.
31. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-7922.
32. Serhan CN, Haeggstrom JZ, Leslie CC. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J 1996; 10; 1147-1158.
33. Bocci V, Luzzi E, Corradeschi F. Studies on the biological effects of ozone: 3. An attempt to define condition for optimal induction of cytokine. Lymphokine Cytokine Res 1993; 12: 121-126.
34. Hatch GE. Commentary on 'Cellular, biochemical and functional effects of ozone: new research and perspectives on ozone health effects'. Toxicol Lett 1990; 51: 119-120.
35. Sanhueza PA, Reed GD, Davis WT, Miller TL. An environmental decision-making tool for evaluating ground-level ozone-related health effects. J Air Waste Manage Assoc 2003; 53: 1448-1459.
36. Sweet F, Kao MS, Lee S. Ozone selectively inhibits growth of human cancer cells. Science 1980; 209: 931-933.
37. Pryor WA. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Free Radic Biol Med 1994; 17: 451-465.
38. Bocci V, Di Paolo N, Borrelli E, Larini A, Cappelletti F. Ozonation of blood during extracorporeal circulation II. Comparative analysis of several oxygenators-ozonators and selection of one type, Int J Artif Org 2001; 24: 890-897.
39. Bocci V, Di Paolo N, Garosi G et al. Ozonation of blood during extracorporeal circulation. I. Rationale, methodology and preliminary studies. Int J Artif Org 1999; 22: 645-651.
40. Bocci V, Di Paolo N. Oxygenation and ozonization of blood during extracorporeal circulation. 3. A new medical approach. Ozone Sci Eng 2004; 26: 195-205.
41. Di Paolo N, Bocci V, Cappelletti F, Petrini G, Gaggiotti E. Necrotizing fasciliitis successfully treated with EBOO (extracorporeal blood oxygenation and ozonization). Int J Artif Org 2002; 25: 1194-1198.
42. Bocci V. Mistletoe (Viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy: a review. J Biol Regul Homeost Agent 1993; 7: 1-6.
43. Rokitansky O, Rokitansky A, Steiner J, Trubel W, Viebahn R, Washuttl J. Die ozonotherapie bei peripheren, arteriellen Durchblutungs-storungen; klinik, biochemisch und blutgasanalytische Untersuchungen. In: Wasser IAO, Proceedings of the Ozone-Weltkongress, Berlin 1981; 53-75.
44. Morgan DL, Furlow TL, Menzel DB. Ozone-initiated changes in erythrocyte membrane and loss of deformability. Environ Res 1988; 45: 108-117.
45. Shinriki N, Suzuki T, Takama K et al. Susceptibilities of plasma antioxidants and erythrocyte constituents to low levels of ozone. Haematologia 1998; 29: 229-239.
46. Valacchi G, Bocci V. Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Mediat Inflamm 2000; 9: 271-276.
47. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994; 233: 380-385.
48. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1994; 233: 302-310.
49. Morrow JD, Jackson Roberts L. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997: 36: 1-21.
50. Basu S. Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic Res 2004; 38: 105-122.
51. Galli F. Amino acid and protein modifications by oxygen and nitrogen species. Amino Acids 2003; 25: 205-206.
52. Martinez GR, Loureiro AP, Marques SA et al. Oxidative and alkylating damage in DNA. Mutat Res 2003; 544: 115-127.
53. Tylicki L, Nieweglowski T, Biedunkiewicz B, Chamienia A, Debska-Slizien A. The influence of ozonated autohemotherapy on oxidative stress in hemodialysed patients with atherosclerotic ischemia of lower limbs. Int J Artif Org 2003; 26: 297-303.
54. Bocci V. Is ozonotherapy therapeutic? Perspect Biol Med 1998; 42: 141-143.
55. Paulesu L, Luzzi E, Bocci V. Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor α (TNF-α) on human leukocytes. Lymphokyne Cytokine Res 1991; 10: 409-412.
56. Di Paolo N, Bocci V, Gaggiotti E. Ozone therapy. Int J Artif Org 2004; 27: 168-176.
57. Di Paolo N, Bocci V, Gaggiotti E. Ozone therapy and clinical efficacy. Int J Artif Org 2004; 27: 733.
58. Tylicki L. Rutkowski B. Ozone therapy seems to be safe, but is it really clinically effective? Int J Artif Org 2004; 27: 731-732.